Immunobiology of primary intracranial tumors
- 1 July 1977
- journal article
- research article
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery
- Vol. 47 (1) , 35-43
- https://doi.org/10.3171/jns.1977.47.1.0035
Abstract
✓ The avian sarcoma virus-induced glioma model in rats was used to study the effectiveness of immunotherapy, namely, Bacillus Calmette-Guérin (BCG) with or without sarcoma cells and/or chemotherapy with 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU), upon survival times. The most consistent prolongation of survival time was produced by triple therapy: BCG + intraperitoneally administered sarcoma cells + intravenously administered BCNU.Keywords
This publication has 19 references indexed in Scilit:
- Response to Comment on "Oscillations in NF-κB Signaling Control the Dynamics of Gene Expression"Science, 2005
- Chemotherapeutic Drugs Increase Killing of Tumor Cells by Antibody and ComplementScience, 1975
- Inhibitory effects of BCG on adenovirus tumorigenesis: Dependence on administration scheduleInternational Journal of Cancer, 1972
- Immunotherapy of Cancer: Immunospecific Rejection of Tumors in Recipients of Neuraminidase-Treated Tumor Cells Plus BCGScience, 1971
- Inhibition of murine sarcoma virus oncogenesis with living BCGInternational Journal of Cancer, 1971
- Immunotherapy of Cancer: Regression of Tumors after Intralesional Injection of Living Mycobacterium bovisScience, 1971
- Tumor Immunity Produced by the Intradermal Inoculation of Living Tumor Cells and Living Mycobacterium bovis (Strain BCG)Science, 1970
- Facilitation of Rat Mammary Tumour Growth by BCGNature, 1970
- Active Immunotherapy with Corynebacterium parvum and Chemotherapy in Murine FibrosarcomasBMJ, 1970
- A generalized Wilcoxon test for comparing arbitrarily singly-censored samplesBiometrika, 1965